Healing Hearts of Hospitalized Patients
Launched by STANFORD UNIVERSITY · Apr 12, 2025
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Healing Hearts of Hospitalized Patients" is exploring how virtual reality (VR) can help patients feel better during their hospital stay. Specifically, the study aims to see if using VR can reduce pain, anxiety, stress, and feelings of loneliness for adult patients. Researchers will compare the effects of experiencing VR with the help of a trained facilitator to using it on their own. This study is not yet recruiting participants but is looking for adults aged 18 and older who are experiencing anxiety related to their medical condition.
To be eligible for this trial, participants need to be able to understand and follow instructions, have good use of their hands to operate VR equipment, and be stable in their health condition. They should also be comfortable using VR and speak English. However, some individuals may not be able to participate if they have severe cognitive issues, facial injuries that prevent headset use, or other specific health concerns. If chosen for the study, participants can expect to engage with VR as a way to escape from their hospital environment and potentially improve their overall well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 years and above
- • Able to provide informed consent
- • Able to follow commands
- • Adequate motor skills for upper extremities to operate VR equipment
- • Clinically stable
- • Experiencing anxiety related to their medical condition as evidenced by a VAS-A score \>4 at time of enrollment.
- • English speaking
- • Willing to engage in Therapeutic VR
- Exclusion Criteria:
- • Severe cognitive impairment
- • Facial trauma prohibiting headset use
- • Physical limitations in facial, neck, upper extremities that hinder use of VR equipment
- • Aggression or violence
- • Harm to self or others
- • Isolation room
- • History of seizures or other neurological conditions
- • Severe motion sickness
- • Active nausea
- • Severe visual impairment
- • Severe cognitive impairment
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported